Ozempic, known generically as semaglutide, primarily targets Type 2 diabetes. Designed as a glucagon-like peptide-1 (GLP-1) receptor agonist, it helps regulate blood sugar levels. When individuals use Ozempic, their bodies release insulin more effectively, decreasing the amount of glucose produced by the liver. Patients generally experience improved glycemic control, reduced…